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Abstract
Background Fluorescein (FA) and indocyanine-green angi-
ography (ICGA) may offer valuable information concerning
disease severity and prognosis in ocular syphilis. The aim of
the present study is to describe angiographic patterns en-
countered in the context of ocular syphilis, and to explore
the associations between specific angiographic manifesta-
tions and severity of disease presentation, as well as disease
evolution after treatment.
Methods We performed a retrospective institutional study
with the inclusion of 23 patients with ocular syphilis pre-
senting to the uveitis clinic of the Jules-Gonin Eye Hospital
in a 10-year period. FA and ICGAwere performed following
a standard protocol for posterior uveitis. Patterns of fluores-
cence were noted, and statistical associations between each
angiographic pattern and any demographic, clinical, or lab-
oratory parameter at baseline and after treatment were
sought.
Results The presence of any dark dots in ICGA was signif-
icantly associated with anterior uveitis (p00.031). The
presence of hot spots in ICGA was significantly associated
with longer duration of symptoms prior to initial visit (p0
0.032) and with male gender (p00.012). Weak non-
significant trends were found associating vascular staining
in FAwith anterior uveitis (p00.066), vitritis (p00.069), and
younger age (p00.061), as well as disc hyperfluorescence in
FA with seropositivity for HIV (p00.089) and macular
edema in FA with longer disease duration (p00.061). The
presence of any dark dots in ICGA exhibited a weak trend of
association with anterior uveitis and/or vitritis (p00.079).
Conclusions Out of the several associations identified im-
plicating specific angiographic features, we underline the
possible role of the presence of dark dots in ICGA for
identifying active inflammation, and the role of hot spots
in ICGA as markers of long-standing disease. Vascular
staining in FA appears to be more common in patients with
severe ocular inflammation with presence of anterior uveitis
and/or vitritis.
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Introduction
Ocular involvement in the context of syphilitic infection
presents certain particularities stemming from the close an-
atomic proximity of the eye to the central nervous system.
Ocular syphilis is therefore classified as a variant of neuro-
syphilis, irrespective of compatible findings in the cerebro-
spinal fluid. The classical description of the clinical course
of syphilitic infection in three consecutive stages is less
relevant in the presence of ocular involvement, as reflected
in the Centers for Disease Control (CDC) guidelines for the
management of syphilis that prompt clinicians to treat all
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cases of ocular syphilitic infection as neurosyphilis [1]. The
value of laboratory investigations in determining disease
severity and prognosis in ocular syphilis is limited. Al-
though serum VDRL titers are considered appropriate for
evaluating disease activity and response to treatment in
syphilis, this is less clear in the context of ocular involve-
ment, which is most common in the secondary, but also in
the tertiary stage of the disease, when VDRL serology is
almost invariably negative. Active and potentially debilitat-
ing ocular disease can therefore be accompanied by negative
non-treponemal serology for syphilis [2]. Further laboratory
investigations would therefore be needed to offer clues as
regards disease severity and prognosis. The role of angiog-
raphy in determining disease severity and in predicting
disease evolution after treatment has not been adequately
studied in ocular syphilis.
Fluorescein angiography (FA) has been extensively used
for the evaluation of ocular inflammation in the context of
posterior uveitis [3–5]. As fluorescein sodium fluoresces in
the wavelengths of visible light, its value is mostly limited in
revealing pathology of the superficial structures of the fundus
[6]. Indocyanine-green (ICG), on the other hand, fluoresces on
the infrared spectrum, giving access to the choroidal compart-
ment through the retinal pigment epithelium. ICG leaks un-
impaired from fenestrated choriocapillaris, albeit slowly,
gradually impregnating choroidal tissue and giving rise to
intermediate and late choroidal background fluorescence in
the course of the angiogram. This fluorescence and its distur-
bance from choroidal inflammatory lesions are the main com-
ponents studied in ICG angiography (ICGA) performed for
posterior granulomatous uveitis [7–9].
FA manifestations of ocular syphilis have been reported
in previous publications, identifying non-specific patterns of
retinal inflammation, such as retinal and vascular staining,
capillary leakage, macular edema, and optic disc hyperfluor-
escence [3–5]. A pattern unique to the disease has been
described by Gass [10], corresponding to the entity named
syphilitic posterior placoid chorioretinitis. ICGA patterns in
ocular syphilis have been described in a case series by Mora
et al., emphasizing the presence of late scattered hyperfluor-
escence as characteristic to the disease [11].
The purpose of the present study is to describe angio-
graphic patterns in ocular syphilis both in fluorescein and
ICG angiography, and to look for meaningful associations
between specific angiographic findings and any baseline
demographic or clinical parameter, as well as disease evo-
lution after treatment and probability for relapse.
Methods
We retrospectively reviewed the charts of 26 patients with
ocular inflammation and a positive treponemal serologic test
for syphilis presenting to the Uveitis department of the
Jules-Gonin Eye Hospital in the period between January
1999 and December 2009. Inclusion criteria for this study
were signs of uveitis compatible with ocular syphilis on
clinical evaluation, together with a positive TPHA or
FTA-Abs test. Medical history and serology for each
patient were discussed with an infectious disease spe-
cialist (SG), in order to ascertain diagnosis of syphilis
and determine stage of disease progression. All patients
were followed by the same uveitis specialist (YGC), and
according to official recommendations laid down for the
management of ocular syphilis [1]. Treatment consisted
of either a standard regimen of intravenous penicillin
for neurosyphilis at a dose of 6 × 4 MO IU per day for
14 days, or an alternative regimen of intravenous cef-
triaxone at a dose of 2 gr per day for 14 days. Inclusion
criteria, clinical and laboratory evaluations, and manage-
ment are extensively discussed in a previous publica-
tion. Associations drawn from the same study sample as
regards disease severity at baseline and disease evolu-
tion after treatment have also been previously reported
[12]. Out of the 26 patients, three refused to enter into
the proposed follow-up including fluorescein and ICG
angiography, lumbar puncture, and visual field assess-
ment. Twenty-three patients underwent dual fluorescein
and ICG angiography following a standard protocol for
the evaluation of posterior uveitis at the moment of disease
diagnosis [13]. The same angiographic evaluation was per-
formed after the completion of a treatment cycle for ocular
syphilis in 17 patients.
As angiography constitutes an examination not readily
quantifiable in clinical practice, and its interpretation remains
to a large extent descriptive, we employed a qualitative ap-
proach to the recording of angiographic findings, noting the
presence or absence of each characteristic pattern, but not its
extent. This was mainly done in order to proceed to a concise,
parsimonious statistical analysis of angiographic findings,
given the small study sample.
Recorded angiographic patterns in FA included macular
edema, disc hyperfluorescence, retinal staining, vascular
staining, retinal ischemia, pinpoint leakage, mask effect
from preretinal hemorrhage, window defects, and fluoresce-
in leakage from choroidal or retinal neovascularization.
Recorded angiographic patterns in ICGA included: (1)
persistent dark dots, defined as diversely sized hypofluor-
escent areas already present in the early and intermediate
phases of the angiogram and remaining hypofluorescent in
the late phase, (2) vanishing dark dots, different in that they
became isofluorescent in the late phase of the angiogram,
and (3) atrophic dark dots, a sub-variant of persistent dark
dots remaining unaltered in subsequent angiograms after
proper antibiotic treatment. Other noted angiographic features
included hot spots, defined as scattered hyperfluorescent foci
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in the posterior pole or the mid-periphery in late angiographic
frames, and fuzzy choroidal vessels observed in the interme-
diate phase of the angiogram.
With regard to statistical analysis of observed angio-
graphic patterns, the following angiographic features were
set as main factors in a series of univariate comparisons:
retinal staining, vascular staining, disc hyperfluorescence,
and macular edema in FA, as well as the presence of any
dark dots and hot spots in ICGA. More specifically, the
associations between the main factors and all registered
demographic, clinical or laboratory parameters (ten in total)
at baseline were thoroughly assessed. The aforementioned
parameters included gender, age at diagnosis, unilateral or
bilateral involvement, HIV status, duration of symptoms
prior to initial visit, pain as a calling sign, anterior uveitis,
vitritis, optic nerve involvement [as evidenced by a relative
afferent pupillary defect (RAPD), and/or optic disc swell-
ing], and relapse of inflammation after treatment. A further
parameter, constituting an indicator of active ocular inflam-
mation, was examined against all registered angiographic
manifestations; the presence of anterior uveitis and/or vitritis
vs the absence of both.
Inter-eye correlations implicating specific angiographic
manifestations in cases with bilateral disease involvement
were calculated in order to identify the degree of symmetry
in FA and ICGA of ocular syphilis with bilateral involve-
ment. Associations among the various angiographic mani-
festations both in FA and in ICGA were also sought.
Pearson’s chi-square, Fisher’s exact test and the Mann–
Whitney–Wilcoxon test for independent samples (MWW)
were appropriately applied in the light of deviation from
normality (as evidenced from Kolmogorov–Smirnov and
Shapiro–Wilk tests). With regard to continuous variables,
median values and inter-quartile ranges are reported given
the nonparametric statistical approach adopted. The level of
statistical significance was set to 5%. A patient-based anal-
ysis was performed in order to circumvent the potential
inter-eye correlation in cases with bilateral involvement;
the presence of any specific angiographic manifestation in
any particular patient was only included once in the analysis
irrespective of unilateral or bilateral involvement, thus elim-
inating the effect of inter-eye correlation. In simple terms, at
the patient-based analysis, each patient was deemed positive
regarding an angiographic manifestation when one or both
eyes had exhibited the respective manifestation. Neverthe-
less, an alternative eye-based analysis was also performed,
and is thoroughly presented in the Appendix, ensuring a
comprehensive approach to available data. Given the ex-
ploratory nature of the present study, no adjustment of the
significance level to account for multiple statistical compar-
isons was deemed to be warranted. Taking into account the
small sample size, no multivariate analysis was performed.
Observed associations may therefore be prone to mutual
confounding which cannot be further investigated by multi-
variate analysis in the context of this study. Statistical anal-
ysis was performed with STATA 8.0 statistical software
(Stata Corporation, College Station, TX, USA).
Institutional Review Board (IRB)/ Ethics Committee ap-
proval of the University of Lausanne was obtained. De-
scribed research adhered to the tenets of the Declaration of
Helsinki.
Results
Simultaneous fluorescein and ICG angiography were per-
formed in 23 patients (39 eyes) at presentation, following a
standard angiographic protocol for the evaluation of poste-
rior uveitis. The most frequent patterns of fluorescence in
FA and ICGA are presented in Table 1. The features most
frequently observed in FA were retinal staining of focal
punctate retinal lesions (43.5%), followed by staining of
retinal vessels, mainly veins (30.4%) and disc hyperfluor-
escence (30.4%) (Fig. 1). Four patients presented a particu-
lar angiographic pattern consisting of hypofluorescent foci
corresponding to the presence of chorioretinal scars, sur-
rounded by hyperfluorescent areas in the late phase, an
aspect compatible with syphilitic posterior placoid chorior-
etinitis. ICGA features could be classified into three main
patterns. The first pattern consisted of hypofluorescent cho-
roidal lesions, visible from the early and intermediate phases
of the angiogram onwards, which either became isofluores-
cent in the late phases, or remained hypofluorescent. These
lesions, also referred to as dark dots, varied considerably in
size, number and localisation, sharing the common charac-
teristic of being invisible in fluorescein angiography or
Table 1 Findings in fluorescein and indocyanine-green angiography
(n023 and 22 patients respectively)
N (%)
Findings in fluoroangiography (n023)
Disc hyperfluorescence 7 (30.4)
Macular edema 4 (17.4)
Vascular staining 7 (30.4)
Retinal staining and/or capillary leakage 10 (43.5)
Retinal ischemia 2 (8.7)
Normal 2 (8.7)
Findings in ICGA (n022)
Dark dots 13 (59.1)
Persistent dark dots exclusively 3 (13.6)
Persistent and vanishing dark dots 10 (45.5)
Hot spots 11 (50.0)
Fuzzy choroidal vessels 5 (14.7)
Normal 3 (8.8)
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fundoscopy, and were observed in 13 patients (59.1%)
(Fig. 2). The second pattern corresponded to scattered
hyperfluorescent spots (hot spots) appearing in the late
phases of the angiogram, in the mid-periphery and/or the
posterior pole present in 11 patients (50%). The third pattern
was fuzzy choroidal vessels with leakage from the interme-
diate phase of the angiogram onwards in five patients
(14.7%). In 13.6% of patients, the persistent variant of dark
dots that remained unaltered in the late frames of the angio-
gram was observed, while 45.5% of patients presented both
persistent and vanishing dark dots, the latter becoming iso-
fluorescent in late frames. Seventeen patients were submitted
to the same angiographic investigations after the completion
of an antibiotic treatment regimen for neurosyphilis. Where
comparison was possible, in FAvascular staining disappeared
after treatment in five out of seven cases (71.4%), disc hyper-
fluorescence in five out of seven cases (71.4%), and retinal
staining in four out of ten cases (40%). In ICGA, three cases of
persistent dark dots remaining unaltered in size after treat-
ment, corresponding to chorioretinal scars, were identified.
Hot spots disappeared in almost every case after treatment (9
out of 11 patients, 82%) (Fig. 3).
Out of the 23 patients, 13 had inflammatory signs
evidenced by the presence of anterior uveitis and/or vitritis,
whereas ten did not. Out of the latter patients, six had
concomitant optic nerve involvement, two had posterior
placoid chorioretinitis, three had retinal staining in FA, and
only one had vascular staining, whereas no patient without
anterior uveitis and/or vitritis presented with macular ede-
ma. With regard to dark dots, which were more common in
eyes with anterior uveitis and/or vitritis though not in a
statistically significant way, they were present in all four
cases that presented relapse of inflammation after proper
antibiotic treatment.
Fig. 1 a Fundus photograph
depicting snowballs in the
vitreous. b, d Extensive central
and peripheral retinal staining
and/or capillary leakage in FA.
c Foci of peripheral retinal
vascular staining in FA
724 Graefes Arch Clin Exp Ophthalmol (2012) 250:721–730
Fig. 2 a Fundus photograph depicting normal retina. b FA of the same case revealing minimal retinal staining. c ICGA of the same case revealing
extensive dark dots and some hot spots, invisible on both fundus photograph and FA
Associations among the various angiographic manifesta-
tions in FA and ICGA are presented in the triangular Table 2.
It is obvious that no significant associations could be iden-
tified, other than a weak trend implicating vascular staining
and macular edema in FA (p00.067, Fisher’s exact test),
though not reaching statistical significance.
Associations between the two most frequent angiograph-
ic manifestations in FA, retinal staining and vascular stain-
ing, and all registered baseline factors are presented in
Tables 3 and 4 respectively. With regard to associations
implicating specific angiographic features, vascular staining
in FA exhibited a weak trend of association with vitritis (6/
12 patients with vitritis also exhibited vascular staining in
FA, whereas only 1/11 patients without vitritis exhibited
vascular staining, p00.069, Fisher’s exact test), anterior uve-
itis (5/9 patients with anterior uveitis presented with vascular
staining vs 2/14 patients without anterior uveitis, p00.066,
Fisher’s exact test) and younger age at presentation [39.0 years
(inter-quartile range (IQR) 9.2] for patients with vascular
staining vs 47.8 (IQR 14.8) for those without, p00.061,
Mann–Whitney–Wilcoxon test), though none of the associa-
tions reached statistical significance. A strong association
between presence of anterior uveitis and presence of vitritis
was also identified (p00.015, Fisher’s exact test). The associ-
ation between vascular staining in fluorescein angiography
with worse visual acuity at baseline did not reach formal
statistical significance (p00.072, MWW), though there was
a significant association with improvement in visual acuity
after treatment (p00.005), as exhaustively described in a
previous publication [12]. There was a weak trend of associ-
ation between disc hyperfluorescence in FA and seropositivity
for HIV infection (2/2 patients with HIV also exhibited disc
hyperfluorescence vs only 5/21 patients without HIV infec-
tion, p00.083, Fisher’s exact test) as well as between macular
edema in FA and longer disease duration prior to initial
presentation [225 days (IQR 122) for patients with macular
edema vs 12 (IQR 23) for patients without macular edema, p0
0.061, MWW], though the associations did not reach statisti-
cal significance. As expected, disc hyperfluorescence was
significantly associated with optic nerve involvement (p<
0.001). All other associations implicating specific FA mani-
festations were non-significant.
Associations between the presence of any dark dots in
ICGA and any other parameter are presented in Table 5. The
presence of any dark dots was significantly associated with
anterior uveitis (p00.031, Fisher’s), while dark dots were
more common in patients with anterior uveitis and/or vitritis
(p00.079, Fisher’s). The presence of any hot spots in ICGA
was associated with male gender (p00.012, Fisher’s) and
longer duration of symptoms prior to initial visit (p00.032,
MWW), as can be seen in Table 6. The former association
remained significant even after the exclusion of patients
positive for HIV infection (p00.008, Fisher’s). There was,
however, no association between hot spots and any sign of
active ocular inflammation.
In cases with bilateral disease, angiographic manifesta-
tions strongly correlated between fellow eyes as follows:
retinal staining (rho00.854, p00.005), vascular staining
Fig. 3 a ICGA revealing hot
spots. b Disappearance of hot
spots after treatment
Table 2 Associations between the various angiographic manifestations in FA and ICGA
Retinal staining Vascular staining Disc hyperfluorescence Macular edema Dark dots Hot spots
Retinal staining —
Vascular staining 0.405 —
Disc hyperfluorescence 0.405 >0.999 —
Macular edema 0.104 0.067 0.557 —
Dark dots 0.674 0.648 0.648 0.616 —
Hot spots >0.999 >0.999 >0.999 >0.999 >0.999 —
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(rho00.779, p00.038), macular edema (rho00.779, p0
0.038), dark dots (rho00.810, p00.024),and hot spots
(rho00.837, p00.010). Disc hyperfluorescence did not ex-
hibit a significant correlation in cases with bilateral disease
(rho00.426, p00.203), with rho values corresponding to
Pearson’s correlation coefficient and p-values deriving from
Fisher’s exact test. In the eye-based analysis, a shift was
observed of some statistically non-significant results to-
wards statistical significance, as is thoroughly presented in
the Appendix.
Discussion
We conducted this exploratory study in search of associations
between specific angiographic manifestations and several
baseline demographic, clinical, or laboratory parameters. As
regards the associations implicating specific angiographic
manifestations in FA, only the one between vascular staining
and improvement in visual acuity after treatment reached
formal statistical significance. Several weak trends of associ-
ation were, however, highlighted in this analysis, specifically
Table 3 Variables associated with retinal staining (patient-based anal-
ysis). Percentages are given with 100% corresponding to each row
Retinal
staining
No retinal
staining
Categorical variables Freq (%) Freq (%) P
Gender >0.999F
Male (n016) 7 (43.8) 9 (56.3)
Female (n07) 3 (42.9) 4 (57.1)
Involvement 0.402F
Unilateral (n010) 3 (30.0) 7 (70.0)
Bilateral (n013) 7 (53.9) 6 (46.2)
HIV status 0.486F
Positive (n02) 0 (0.0) 2 (100.0)
Negative (n021) 10 (47.6) 11 (52.4)
Pain as a calling sign 0.074F
Yes (n08) 1 (12.5) 7 (87.5)
No (n015) 9 (60.0) 6 (40.0)
Optic neuropathy > 0.999F
Yes (n09) 4 (44.4) 5 (55.6)
No (n014) 6 (42.9) 8 (57.1)
Anterior uveitis >0.999F
Yes (n09) 4 (44.4) 5 (55.6)
No (n014) 6 (42.9) 8 (57.1)
Vitritis 0.214F
Yes (n012) 7 (58.3) 5 (41.7)
No (n011) 3 (27.3) 8 (72.7)
Anterior uveitis
and/or vitritis**
0.402F
Yes (n013) 7 (53.9) 6 (46.1)
No (n010) 3 (30.0) 6 (70.0)
Relapse after treatment 0.582F
Yes (n04) 1 (25.0) 3 (75.0)
No (n015) 8 (53.3) 7 (46.7)
Continuous variables Median
(IQR)
Median
(IQR)
P
Age (years) 43.0 (11.5) 47.6 (11.8) 0.385MWW
Duration of symptoms
prior to initial visit
(days)
36 (87) 90 (146) 0.755MWW
F Fisher's exact test
MWW Mann–Whitney–Wilcoxon test
Table 4 Variables associated with vascular staining (patient-based
analysis). Percentages are given with 100% corresponding to each row
Vascular
staining
No vascular
staining
Categorical variables Freq (%) Freq (%) P
Gender >0.999F
Male (n016) 5 (31.2) 11 (68.8)
Female (n07) 2 (28.6) 5 (71.4)
Involvement 0.650F
Unilateral (n010) 4 (40.0) 6 (60.0)
Bilateral (n013) 3 (23.1) 10 (76.9)
HIV status 0.526F
Positive (n02) 1 (50.0) 1 (50.0)
Negative (n021) 6 (28.6) 15 (71.4)
Pain as a calling sign 0.182F
Yes (n08) 4 (50.0) 4 (50.0)
No (n015) 3 (20.0) 12 (80.0)
Optic neuropathy > 0.999F
Yes (n09) 3 (33.3) 6 (66.7)
No (n014) 4 (28.6) 10 (71.4)
Anterior uveitis 0.066F
Yes (n09) 5 (55.6) 4 (44.4)
No (n014) 2 (14.3) 12 (85.7)
Vitritis 0.069F
Yes (n012) 6 (50.0) 6 (50.0)
No (n011) 1 (9.1) 10 (90.9)
Anterior uveitis
and/or vitritis**
0.089F
Yes (n013) 6 (46.1) 7 (53.9)
No (n010) 1 (10.0) 9 (90.0)
Relapse after treatment 0.557F
Yes (n04) 2 (50.0) 2 (50.0)
No (n0 15) 4 (26.7) 11 (73.3)
Continuous variables Median
(IQR)
Median
(IQR)
P
Age (years) 39.0 (9.2) 47.8 (14.8) 0.061MWW
Duration of symptoms
prior to initial visit
(days)
7 (147) 75 (115.5) 0.946MWW
F Fisher's exact test
MWW Mann–Whitney–Wilcoxon test
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between vascular staining and anterior uveitis, vitritis, anterior
uveitis and/or vitritis, worse visual acuity at presentation, and
younger age at presentation, as well as between disc hyper-
fluorescence and seropositivity for HIVand between macular
edema and longer disease duration prior to the initial visit. The
findings implicating vascular staining may point to a close
association between these markers of active inflammation,
indicating that eyes with vascular staining are more severely
inflamed, which in turn may account for the weak trend
towards worse BCVA at baseline in these patients. As
evidenced in our previous study, improvement in visual acuity
after treatment was significantly associated with presence of
vascular staining in FA, underlining the reversible nature of
this type of ocular inflammatory reaction in the context of
ocular syphilis [12]. The high rate of disappearance of vascu-
lar staining in FA performed after treatment points to the same
conclusion, indicating that vasculitis is not accompanied by
permanent visual repercussions in ocular syphilis, when prop-
erly treated. The fact that all patients with HIV seropositivity
Table 5 Variables associated with dark dots (patient-based analysis).
Percentages are given with 100% corresponding to each row
Dark dots No dark
dots
Categorical variables Freq (%) Freq (%) P
Gender >0.999F
Male (n0 16) 9 (56.3) 7 (43.7)
Female (n06) 4 (66.7) 2 (33.3)
Involvement 0.192F
Unilateral (n0 10) 4 (40.0) 6 (60.0)
Bilateral (n0 12) 9 (75.0) 3 (25.0)
HIV status >0.999F
Positive (n0 2) 1 (50.0) 1 (50.0)
Negative (n020) 12 (60.0) 8 (40.0)
Pain as a calling sign >0.999F
Yes (n08) 5 (62.5) 3 (37.5)
No (n014) 8 (57.1) 6 (42.9)
Optic neuropathy 0.674F
Yes (n09) 6 (66.7) 3 (33.3)
No (n013) 7 (53.9) 6 (46.1)
Anterior uveitis 0.031F
Yes (n09) 8 (88.9) 1 (11.1)
No (n013) 5 (38.5) 8 (61.5)
Vitritis 0.192F
Yes (n012) 9 (75.0) 3 (25.0)
No (n010) 4 (40.0) 6 (60.0)
Anterior uveitis
and/or vitritis**
0.079F
Yes (n0 13) 10 (76.9) 3 (23.1)
No (n09) 3 (33.3) 6 (66.7)
Relapse after treatment 0.245F
Yes (n04) 4 (100.0) 0 (0.0)
No (n015) 8 (53.3) 7 (46.7)
Continuous variables Median
(IQR)
Median
(IQR)
P
Age (years) 45.1 (9.1) 42.2 (11.8) 0.867MWW
Duration of symptoms
prior to initial visit
(days)
12 (147) 90 (83) 0.867MWW
F Fisher's exact test
MWW Mann–Whitney–Wilcoxon test
Table 6 Variables associated with hot spots (patient-based analysis).
Percentages are given with 100% corresponding to each row
Hot Spots No Hot
Spots
Categorical variables Freq(%) Freq(%) p
Gender* 0.012F
Male (n016) 11 (68.8) 5 (31.2)
Female (n06) 0 (0.0) 6 (100.0)
Involvement 0.670F
Unilateral (n010) 6 (60.0) 4 (40.0)
Bilateral (n012) 5 (41.7) 7 (58.3)
HIV status 0.476F
Positive (n02) 0 (0.0) 2 (100.0)
Negative (n020) 11 (55.0) 9 (45.0)
Pain as a calling sign 0.659F
Yes (n08) 3 (37.5) 5 (62.5)
No (n014) 8 (57.1) 6 (42.9)
Optic neuropathy > 0.999F
Yes (n09) 4 (44.4) 5 (55.6)
No (n013) 7 (53.9) 6 (46.1)
Anterior uveitis >0.999F
Yes (n09) 4 (44.4) 5 (55.6)
No (n013) 7 (53.9) 6 (46.1)
Vitritis 0.670F
Yes (n012) 7 (58.3) 5 (41.7)
No (n010) 4 (40.0) 6 (60.0)
Anterior uveitis
and/or vitritis**
0.387F
Yes (n013) 8 (61.5) 5 (38.5)
No (n09) 3 (33.3) 6 (66.7)
Relapse after treatment 0.582F
Yes (n04) 1 (25.0) 3 (75.0)
No (n015) 8 (53.3) 7 (46.7)
Continuous variables Median
(IQR)
Median
(IQR)
P
Age (years) 39.0 (18.4) 45.1 (8.9) 0.376MWW
Duration of symptoms
prior to initial visit
(days)
90 (210) 7 (59) 0.032MWW
* After the exclusion of patients with HIV infection, the association
persists (11/15 males vs 0/5 females exhibit hot spots in ICG, p00.008)
F Fisher's exact test
MWW Mann–Whitney–Wilcoxon test
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exhibited disc hyperfluorescence in FA, illustrates a probable
previously unrecognised site of preferential posterior involve-
ment of ocular syphilis in the context of HIV co-infection. The
potential increased prevalence of macular edema in patients
with longer duration of intra-ocular inflammation has been
suspected in uveitis [14], and may point to a deleterious effect
of persistent inflammatory stimuli, leading to gradual accu-
mulation of intraretinal fluid in the macular area. The aspect of
“leopard spots” in fluorescein angiography described by Gass
[10] in the context of syphilitic posterior placoid chorioretinitis
as being highly indicative of syphilitic infection was also
observed in four patients in our series. Interestingly, patients
without anterior uveitis and/or vitritis mainly presented with
optic nerve involvement, and to a lesser extent posterior placoid
chorioretinitis and retinal staining, though only one such patient
exhibited vascular staining, and none had macular edema.
Similar patterns in ICGA to those observed in our series
have been described in other forms of granulomatous pos-
terior uveitis, such as sarcoidosis and tuberculosis [15, 16],
and are not unique to ocular syphilis. Probable interpreta-
tions for the above mentioned patterns are atrophy, fibrosis,
or full-thickness granuloma for persistent dark dots, partial
thickness granuloma or delayed perfusion of choriocapillaris
for vanishing dark dots, and choroidal vasculitis for fuzzy
choroidal vessels. Dark dots have also been described in
ocular sarcoidosis and ocular tuberculosis, the latter alleg-
edly being associated with more extensive and more conflu-
ent lesions [17]. Our study revealed a significant association
between presence of dark dots and anterior uveitis, and a
weak trend of association with presence of anterior uveitis
and/or vitritis. It should be emphasized that there was a
strong association between the presence of anterior uveitis
and the presence of vitritis, prompting us to introduce a
combined parameter implicating both inflammatory indica-
tors and to test all baseline factors against this parameter as
well. Dark dots were present in all four patients that
exhibited relapse of inflammation after initial remission fol-
lowing proper antibiotic treatment, though no statistically
significant association could be drawn from such small numb-
ers. We suggest that the presence of dark dots, excluding those
associated with atrophy, may signify active granulomatous
posterior choroidal inflammation. Due to the small sample,
however, we were unable to identify the specific character-
istics of dark dots, for instance size, number, and localisation,
which are more evocative of active inflammation.
With regard to hot spots, although they have been observed
in other granulomatous uveitis, their high prevalence in ocular
syphilis could be characteristic to the disease. These features
have been described in the article by Mora et al. [11], and
probable proposed interpretations include fixing of ICG mole-
cules on active granuloma or staining of leucocytes. These
manifestations have also been alleged to indicate active disease
or long-standing disease. The former assumption was not,
however, statistically confirmed in the present study. On the
contrary, the lack of association between hot spots and any
ocular manifestation with important functional repercussions,
such as macular edema, optic neuropathy, or anterior uveitis,
may reveal an exclusively choroidal origin of these angiograph-
ic features. On the other hand, the identified association be-
tween the presence of hot spots and a longer duration of
symptoms prior to the first visit may render this angiographic
finding indicative of long-standing disease. Hot spots appeared
to be significantly more common in male patients. This asso-
ciation, though persisting even after the exclusion of patients
with HIV co-infection, was rather more difficult to interpret.
Surprisingly, no association could be identified between
various angiographic manifestations both in FA and ICGA,
other than a weak positive trend implicating vascular staining
and macular edema. Although both vascular staining in FA
and dark dots in ICGA appear to be more common in eyes
with anterior uveitis and/or vitritis, they do not seem to co-
exist in the same eye. This observation, in conjunction with
the absence of any other association between ICGA findings
and any clinical parameter indicative of retinal inflammation
such as retinal staining or macular edema, could justify the
speculation of two morphologically and angiographically dis-
tinct patterns of syphilitic eye disease, namely a predominant-
ly choroidal versus a predominantly retinal variant.
Inter-eye correlation of angiographic manifestations in
case of bilateral disease involvement appears significant
and strong as regards all main factors apart from disc hyper-
fluorescence. This analysis makes it possible to provide
useful insight into the degree of correlation of angiographic
findings between fellow eyes in bilateral ocular syphilis,
which has not so far been reported. Given the high degree
of inter-eye correlation of angiographic manifestations iden-
tified, the use of a patient-based analysis becomes even
more appropriate in the context of the present study.
This study has certain limitations stemmingmainly from its
retrospective design and the small study sample. A further
shortcoming lies in the loss of six patients to follow-up with
regard to angiographic evaluation after treatment, further lim-
iting our ability to assess the effect of treatment on observed
angiographic patterns. It should also be emphasized that given
the small study sample, multivariate analysis could not be
performed so as to avoid over-interpretation of available data.
Observed associations may therefore be prone to mutual con-
founding, and their independence may not be warranted.
We conclude, based on our findings, that angiographic
investigation in ocular syphilis can offer valuable informa-
tion concerning disease severity and duration, and can even
contribute some clues to disease prognosis. Vascular stain-
ing in FA and dark dots in ICGA appear to be more common
in more severely inflamed eyes with anterior uveitis and/or
vitritis, whereas hot spots are more often present in patients
with long-standing disease without other signs of severe
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inflammation. Two variants of the disease, one with predom-
inantly choroidal involvement and one predominantly retinal,
could be hypothesized. In view, however, of the exploratory
nature of the current study and the above-mentioned limita-
tions, further corroborative studies are required to confirm our
findings. Nevertheless, some earlier arbitrary hypotheses
concerning the significance of specific angiographic features
in granulomatous posterior uveitis were for the first time
statistically investigated in the present study.
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Appendix
An eye-based analysis of registered data was performed in
the service of comprehensiveness and in an attempt to
exploit all available data. Angiographic manifestations en-
countered in FA and ICGA on an eye basis are presented in
Table 7. With regard to associations implicating specific
angiographic features, vascular staining in FA exhibited a
statistically significant association with vitritis (8/19 eyes
with vitritis also exhibited vascular staining in FA, whereas
only 1/17 eyes without vitritis exhibited vascular staining,
p00.020), anterior uveitis (7/15 eyes with anterior uveitis
presented with vascular staining vs 2/21 eyes without anterior
uveitis, p00.019) and a weak trend implicating macular edema
(4/8 eyes with macular oedema vs 5/28 eyes without macular
edema exhibited vascular staining, p00.086), with p-values
derived from Fisher’s exact test. The association between
vascular staining in fluorescein angiography with worse visual
acuity at baseline did not reach formal statistical significance
(p00.072, MWW), though there was a significant association
with improvement in visual acuity after treatment (p00.005), as
exhaustively described in a previous publication [12]. Disc
hyperfluorescence in FA was significantly associated with se-
ropositivity for HIV infection (3/3 eyes with HIValso exhibited
disc hyperfluorescence vs only 6/33 eyes without HIV infec-
tion, p00.012, Fisher’s exact test).
Associations between the presence of any dark dots in
ICGA and any other parameter are presented in Table 8. The
presence of any dark dots was significantly associated with
Table 7 Findings in fluorescein and indocyanine-green angiography
(n039 eyes)
N (%)
Findings in fluoroangiography (n036)
Disc hyperfluorescence 9 (25.0)
Macular edema 5 (13.9)
Vascular staining 9 (25.0)
Retinal staining and/or capillary leakage 15 (41.7)
Retinal ischemia 3 (6.5)
Normal 3 (6.5)
Findings in ICGA (n034)
Dark dots 21 (61.8)
Persistent dark dots 4 (11.8)
Persistent and vanishing dark dots 17 (50.0)
Hot spots 15 (44.1)
Fuzzy choroidal vessels 5 (14.7)
Normal 3 (8.8)
Table 8 Variables associated with dark dots (eye-based analysis).
Percentages are given with 100% corresponding to each row
Dark dots No dark dots
Categorical variables Freq(%) Freq(%) P
Anterior uveitis 0.013F
Yes (n015) 13 (86.7) 2 (13.3)
No (n019) 8 (42.1) 11 (57.9)
Vitritis 0.034F
Yes (n019) 15 (79.0) 4 (21.0)
No (n015) 6 (40.0) 9 (60.0)
Vascular staining in FA 0.427F
Yes (n09) 7 (77.8) 2 (22.2)
No (n025) 14 (56.0) 11 (44.0)
Relapse after treatment 0.066F
Yes (n07) 7 (100.0) 0 (0.0)
No (n024) 14 (58.3) 10 (41.7)
F p-value derived from Fisher’s exact test
Table 9 Variables associated with hot spots (eye-based analysis).
Percentages are given with 100% corresponding to each row
Hot spots No hot
spots
Categorical variables Freq (%) Freq (%) P
Gender <0.001F
Male (n023) 15 (65.2) 8 (34.8)
Female (n011) 0 (0.0) 11 (100.0)
Relapse 0.201F
Yes (n07) 1 (14.3) 6 (85.7)
No (n024) 11 (45.8) 13 (54.2)
Continuous variables Median
(IQR)
Median
(IQR)
P
Duration of symptoms
prior to initial visit
(days)
7 (149) 120 (210) 0.007MWW
F p-value derived from Fisher’s exact test; MWW p-value derived from
Mann–Whitney–Wilcoxon test for independent samples; IQR: inter-
quartile range
Graefes Arch Clin Exp Ophthalmol (2012) 250:721–730 729
anterior uveitis (p00.013), vitritis (p00.034), while dark
dots were observed in all seven eyes with relapse of inflam-
mation after proper antibiotic treatment (p00.066). The
presence of any hot spots in ICGAwas associated with male
gender (p<0.001) and longer duration of symptoms prior to
initial visit (p00.007), as can be seen in Table 9. There was,
however, no association with relapse of inflammation after
treatment (p00.201).
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